AAV Capsid Engineering to Modify the Immune Response

Time: 9:30 am
day: Conference Day One

Details:

• Which capsid components are predictive of a negative immune response?
• Presenting a capsid engineering approach to dampen innate and adaptive immune responses
• Outlining engineering methodology to derive the novel capsid variant
• Analyzing In vivo performance and addressing human translatability challenges

Speakers:

Jing Liao Jing Liao is Head of Vector Technology at Alexion Pharmaceuticals. Her team is focusing on capsid engineering to improve the properties of the capsids. She Read more